Please enable JS
 
 

IN THE NEWSVIEW ALL

img

Amgen Just Slashed Its Price of the Cholesterol-Lowering Drug Repatha. So What Does This Mean for You?

Oct 29/

You may have heard that Amgen, which manufactures the cholesterol-lowering drug evolocumab (Repatha), just announced it is lowering the list price of the drug by about 60 percent to $5,850 per year fr

READ MORE
img

New York Proclaims June as Migraine and Headache Awareness Month

Jun 05/

On June 5, 2018 the New York State Assembly and Senate adopted a resolution proclaiming June as Migraine and Headache Awareness Month.

READ MORE
Become an Advocate
JOIN US TODAY